Core Insights - Highmark Blue Cross Blue Shield has released a draft medical policy expanding coverage for adolescent and adult patients with major depressive disorder (MDD) to include BrainsWay's accelerated Deep TMS™ protocol [1][2] - The new policy is expected to take effect in February 2026, following an open comment period, and will cover BrainsWay's accelerated SWIFT™ protocol, which involves a total of 38 treatment sessions [2] - BrainsWay's accelerated depression protocol for Deep TMS received FDA clearance in September 2025, demonstrating an 87.8% response rate and a 78.0% remission rate in clinical trials [4] Company Overview - BrainsWay is a leader in noninvasive neurostimulation treatments for mental health disorders, with a proprietary Deep TMS™ platform technology [5] - The company has obtained three FDA-cleared indications for its treatments, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction [5] - BrainsWay is committed to advancing neuroscience and increasing global awareness and access to Deep TMS [5]

Core Viewpoint - Royal Philips has been recognized as a Clarivate Top 100 Global Innovator for 2026, marking the 13th consecutive year of this achievement, highlighting its leadership in healthcare innovation [2][6]. Group 1: Innovation and R&D Commitment - Philips invests over EUR 1.7 billion annually in R&D, which is approximately 9% of its sales, positioning it among the highest in the industry [3][6]. - The company focuses on AI-enabled technologies, advanced imaging, and connected platforms to enhance diagnosis precision and streamline workflows [3][6]. Group 2: Notable Innovations - Philips Verida is introduced as the world's first detector-based spectral CT, integrating AI throughout the imaging process [7]. - The company has developed helium-free MRI magnet technology, saving over six million liters of liquid helium and eliminating the need for refills in hospitals [7]. - The Philips Flash 5100 Point-of-Care Ultrasound offers advanced imaging clarity and an intuitive workflow for frontline clinical decision-making [7]. - A next-generation web-based diagnostic viewer has been created to improve how radiologists access and interpret medical images [7]. - AI-enabled personal care innovations, such as the Philips i9000 Shaver Series, provide personalized self-care experiences for consumers [7]. Group 3: Company Overview - Philips generated sales of EUR 18 billion in 2024 and employs approximately 67,000 people, with operations in over 100 countries [8].

Core Insights - Royal Philips has been recognized as a Clarivate Top 100 Global Innovator for 2026, marking the 13th consecutive year of this achievement, and is the highest-ranking medical technology company in the report [7][9] - The company emphasizes its commitment to innovation, with over EUR 1.7 billion invested annually in R&D, representing approximately 9% of its sales, which is among the highest in the industry [8][9] - Philips is focused on applying AI-enabled technologies and advanced imaging to enhance healthcare delivery and empower individuals in managing their health [8][10] Innovation Highlights - Philips Verida is introduced as the world's first detector-based spectral CT, integrating AI throughout the imaging process [10] - The company has developed helium-free MRI magnet technology, with over 2,000 installations globally, saving six million liters of liquid helium [10] - The Philips Flash 5100 Point-of-Care Ultrasound offers advanced imaging clarity and an intuitive workflow for frontline clinical decision-making [10] - A next-generation web-based diagnostic viewer has been launched to improve how radiologists access and interpret medical images [10] Consumer Innovations - AI-enabled personal care products, such as the Philips i9000 Shaver Series, provide personalized and intuitive self-care experiences for consumers [11] - The innovations reflect Philips' strategy to enhance both professional healthcare and consumer health through technology [8][11]

Market Overview - U.S. equity markets ended the fourth quarter positively, with the S&P 500 and Nasdaq 100 rising 2.4% and 2.6% respectively, while the Dow Jones Industrial Average led with a 3.6% return [2] - The Russell 1000 Growth Index lagged, increasing only 1.1% as investors shifted from high-growth technology stocks to more defensive sectors [2] - The quarter was marked by significant volatility, influenced by a 43-day government shutdown that affected market transparency and risk appetite [2] Economic and Monetary Policy - Approximately 83% of S&P 500 companies reported positive earnings surprises, indicating a broadening economic recovery beyond the "Magnificent Seven" [4] - The Federal Reserve implemented two 25-basis point cuts, bringing the federal funds rate to a range of 3.50% to 3.75% by year-end, and concluded its quantitative tightening program [4] - The Fed's balance sheet expanded by approximately $100 billion to $6.6 trillion, reflecting a shift from "abundant" to "ample" bank reserves [4] Sector Performance - Ithaka's portfolio underperformed the Russell 1000 Growth Index by 700 basis points, with stock selection detracting 740 basis points from relative performance [6] - Positive relative returns were generated in the Materials and Processing sector, while Technology and Consumer Discretionary sectors were significant sources of underperformance [7] - Weakness in Technology was attributed to fears of AI disintermediating software stocks, while Consumer Discretionary faced pressures from consumer spending concerns [7] Top Contributors and Detractors - Top contributors included Intuitive Surgical (26.6% return), Advanced Micro Devices (32.4%), and Alphabet (28.9%), driven by strong earnings and positive investor sentiment [9][10][12] - Major detractors were ServiceNow (-16.8%), Netflix (-21.8%), and Veeva Systems (-25.1%), with concerns over AI impacts and unexpected financial disclosures affecting stock performance [9][15][16] Investment Strategy and Outlook - Ithaka initiated three new positions and eliminated four during the quarter, with a trailing 12-month turnover of 22.1% [17] - The investment approach focuses on long-term wealth creation through concentrated positions in high-quality companies with strong management and favorable market conditions [4][19] - The narrative around AI is shifting towards tangible productivity gains, suggesting that the economic opportunities from AI will continue to expand [18]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. (a) the publication of this announcement on the Stock Exchange's website does not give rise to any obligation of the Company, its sole sponsor, ov ...

Core Insights - Qingdao is prioritizing technological innovation to enhance new quality productivity, focusing on embodied intelligent robots and an innovative industrial system [1][2][5] Group 1: Technological Innovation - The core element of developing new quality productivity is technological innovation, with embodied intelligent robots being a key strategy for Qingdao to seize future industrial opportunities [2] - Qingdao has established a robust ecosystem with nearly 100 robot and component companies and over 500 AI firms, ranking sixth among China's advanced manufacturing cities [2] Group 2: Industry Development - Qingdao's "10+1" innovative industrial system includes two leading industries, five emerging industries, and three advantageous industries, aiming to enhance productivity across 40 niche sectors [6] - The city is focusing on the integration of traditional industries with digital transformation, exemplified by the development of high-tech products like the world's first 8K laser television and high-speed magnetic levitation transportation systems [7] Group 3: AI and Digital Economy - Qingdao is building a comprehensive digital economy framework, emphasizing the importance of computing power as a "digital engine" for industrial innovation [8] - The city aims to become a provincial hub for computing power, with plans to enhance infrastructure and promote the integration of traditional and digital economies [8][9] Group 4: Achievements and Future Goals - Qingdao's innovation ecosystem has seen significant growth, with the number of technology-based SMEs increasing by 85% and high-tech enterprises by 98% since 2020 [7] - By 2026, Qingdao plans to achieve substantial advancements in AI and new generation information technology, targeting a scale of 200 billion yuan for the AI industry [6][10]

Core Viewpoint - Three stocks in the health care sector are showing signs of being overbought, which may concern momentum-focused investors [1] Group 1: Stock Performance - Venus Concept Inc (NASDAQ:VERO) has seen its stock price increase by approximately 451.8%, closing at $7.89, with a 52-week high of $14.50 and an RSI value of 95.9 [5][3] - ImmunityBio Inc (NASDAQ:IBRX) experienced a stock price rise of 39.8%, closing at $5.52, with a year-to-date increase of over 100% and an RSI value of 95.4 [5][4] Group 2: Investment Activity - Madryn Asset Management disclosed a 91% stake in Venus Concept Inc for investment purposes, indicating strong institutional interest in the company [5]

BEDMINSTER, N.J.--(BUSINESS WIRE)--Retrieve Medical (OTC: RMHI) today announced that it is entering commercial production with Retrieve Passportâ"¢, its proprietary technology platform designed to give individuals secure, portable access to their complete medical record anywhere in the world. The commercial launch marks a major milestone for the company after years of development, regulatory alignment, interoperability integration, and security validation. Retrieve Passport enables individuals to. ...

Core Insights - NeuralCloud Solutions Inc. has announced a strategic collaboration with Movesense Ltd to enhance cardiac monitoring solutions through the integration of wearable ECG devices and AI technology [1][2]. Group 1: Collaboration Overview - The partnership designates Movesense as a primary ECG device partner for NeuralCloud, focusing on developing bundled cardiac monitoring solutions [1]. - The collaboration aims to combine Movesense's wearable single-lead ECG sensors with NeuralCloud's AI-powered platforms, including MaxYield™, CardioYield™, and Insight360™, to improve ECG acquisition and reporting [2][4]. Group 2: Technology and Product Integration - Movesense's lightweight and programmable wearable sensors provide a flexible and cost-effective hardware foundation for ECG monitoring [3]. - The integration of Movesense's sensors with NeuralCloud's AI-driven signal processing allows for comprehensive ECG workflows that surpass traditional methods [3][4]. - Insight360™ offers customizable ECG reports through user-friendly dashboards, while CardioYield™ facilitates structured Holter-style reviews, and MaxYield™ enhances signal quality and data labeling [5]. Group 3: Market Position and Strategy - The collaboration aims to address markets traditionally served by higher-cost Holter monitoring systems, potentially offering more accessible alternatives [4]. - The partnership enhances operational and commercial flexibility, enabling faster deployment and broader market reach for combined hardware and software solutions [6]. - The collaboration reflects a strategic move to embed AI-powered cardiac intelligence into real-world workflows, strengthening the companies' market position [6].

Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company"), a pioneer in health, safety and rapid response technologies, today announced the sale of a NIRLAB SA ("NIRLAB") NIRLIGHT spectroscopy drug analysis device to Far North Resources Inc., representing the first transaction completed under Safe Supply's exclusive Canadian distribution agreement with NIRLAB, and reinforcing its commitment to supporting Indi ...